Contact us

White Paper: Heightened FDA Enforcement for Sterility Issues

NSF analyzed all of the warning letters issued to pharma and biologic manufacturers for sterility issues since 2015. This white paper provides detailed insight into our analysis. It includes relative charts and a table with a summary of the regulations cited by the FDA as well as recommendations for closing your compliance gaps.

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF